Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastrointestinal Cancers
•
Medical Oncology
Would you consider using capecitabine in a patient who previously had encephalopathy with 5-FU?
Related Questions
What are your top takeaways from ASCO GI 2025?
Would you ever consider foregoing surveillance CT scans for resected stage II or III colon cancer in favor of circulating ctDNA assays?
Is there any circumstance where you would consider bevacizumab in patients with locally advanced colorectal cancer with rectouterine fistula?
What is your approach to TNT sequencing for locally advanced rectal primaries with low volume metastatic disease to liver?
What are your first line treatment choices for metastatic combined HCC/Cholangiocarcinoma?
Would you offer zolbetuximab + chemotherapy in a presumed metastatic duodenal bulb adenocarcinoma with 80% Claudin18.2 expression?
What is your institutional practice for neoadjuvant therapy prior to transplanting cholangiocarcinoma?
What is your preferred way of administering nivolumab/ipilimumab in GI cancers?
How do you approach an isolated metastasis to left supraclavicular node in rectal cancer treated with TNT with FOLFOX regimen followed by long course radiation?
Would you consider proton therapy as part of TNT for rectal cancer?
